Anticancer Activity of Chalcones and Its Derivatives: Review and In Silico Studies

Molecules. 2023 May 10;28(10):4009. doi: 10.3390/molecules28104009.

Abstract

Chalcones are direct precursors in the biosynthesis of flavonoids. They have an α,β-unsaturated carbonyl system which gives them broad biological properties. Among the biological properties exerted by chalcones, their ability to suppress tumors stands out, in addition to their low toxicity. In this perspective, the present work explores the role of natural and synthetic chalcones and their anticancer activity in vitro reported in the last four years from 2019 to 2023. Moreover, we carried out a partial least square (PLS) analysis of the biologic data reported for colon adenocarcinoma lineage HCT-116. Information was obtained from the Web of Science database. Our in silico analysis identified that the presence of polar radicals such as hydroxyl and methoxyl contributed to the anticancer activity of chalcones derivatives. We hope that the data presented in this work will help researchers to develop effective drugs to inhibit colon adenocarcinoma in future works.

Keywords: anticancer activity; chalcones; drug discovery; in vitro; natural products; synthesis.

Publication types

  • Review

MeSH terms

  • Adenocarcinoma*
  • Antineoplastic Agents* / pharmacology
  • Chalcones* / pharmacology
  • Colonic Neoplasms* / drug therapy
  • Flavonoids / pharmacology
  • Humans

Substances

  • Chalcones
  • Flavonoids
  • Antineoplastic Agents